News
As customer expectations continue to rise, the ability to adapt quickly and deliver value consistently will define the next ...
When manufacturers begin exploring automation, they often jump straight to the most complex challenge on their production ...
Businesses that embrace AI and low-code automation could be the ones that outpace competitors still trapped by manual work and fragmented systems.
Webinar: Improve Operational Visibility Through Cybersecure Integration of Power and Process Systems
Watch the webinar to explore how automation professionals can improve visibility of industrial operations by integrating ...
Digital debt collection Fintech TrueAccord is focused on redefining the industry by harnessing Robotic Process Automation (RPA) bots. This digital technology streamlines operations while also ...
PLYMOUTH, Minn., April 21, 2025 /PRNewswire/ -- ASI DATAMYTE, Inc. ("DATAMYTE"), a global leader in process improvement and quality control solutions, is excited to announce the incorporation of ...
Hosted on MSN19d
The application of business process hyper automationIn recent years, organisations have successfully used business process hyper automation (BPHA ... resulting in continuous improvement of the process until a Six Sigma level of process quality ...
This process is not only time-consuming but also prone to human errors. AI-powered claims automation is now reshaping the industry, leveraging machine learning (ML) and natural language processing ...
At Hannover Messe 2025, ODVA announced two updates: the addition of level sensors for process device profiles and a new pull model for configuration data for CIP Security, the cybersecurity network ...
Such is the case for Duncan Schleiss, longtime VP of business development at Emerson, who now adds a new title to his legacy—2025 Process Automation Hall of Fame inductee. Schleiss, who many in the ...
Notably, FedRAMP 20x emphasizes automation and industry engagement ... Currently, the traditional FedRAMP Agency Authorization process is the only path to FedRAMP authorization today.
Continuous manufacturing offers advantages in both biotherapeutic and API manufacturing but still poses challenges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results